Literature DB >> 6589609

Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.

K Alitalo, R Winqvist, C C Lin, A de la Chapelle, M Schwab, J M Bishop.   

Abstract

Two cell lines (COLO 201 and COLO 205) derived independently from a single adenocarcinoma of the human colon each harbored an approximately 10-fold amplification of the cellular oncogene c-myb and a proportional abundance of the 4-kilobase mRNA derived from c-myb. By contrast, expression of c-myb could not be detected in cells from a variety of other solid tumors, including other colon carcinomas. Analysis of the amplified DNA with restriction endonucleases failed to reveal any topographical abnormalities within c-myb. Neither COLO 201 nor COLO 205 carry the double minute chromosomes and homogeneously staining regions of chromosomes that frequently serve as karyotypic signatures of amplified DNA. Instead, amplified c-myb is carried on what appear to be disomic or trisomic copies of the same anomalous marker chromosome that is characteristic of both COLO 201 and COLO 205. The karyological origin of this abnormal chromosome is not presently apparent. Our findings show c-myb expression by cells outside of the hemopoietic lineage, raise the possibility that amplification and/or ectopic expression of c-myb may have contributed to the genesis of the tumor from which the cells of COLO 201 and COLO 205 arose, and suggest that amplification of cellular oncogenes may be a more common factor in tumorigenesis than might have been suspected from available karyological data.

Entities:  

Mesh:

Year:  1984        PMID: 6589609      PMCID: PMC345625          DOI: 10.1073/pnas.81.14.4534

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues.

Authors:  T J Gonda; D K Sheiness; J M Bishop
Journal:  Mol Cell Biol       Date:  1982-06       Impact factor: 4.272

2.  Molecular cloning of the avian myelocytomatosis virus genome and recovery of infectious virus by transfection of chicken cells.

Authors:  B Vennström; C Moscovici; H M Goodman; J M Bishop
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

3.  Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29.

Authors:  K Alitalo; J M Bishop; D H Smith; E Y Chen; W W Colby; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line.

Authors:  S Collins; M Groudine
Journal:  Nature       Date:  1982-08-12       Impact factor: 49.962

5.  Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient.

Authors:  R Dalla-Favera; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

6.  Localization of single copy DNA sequences of G-banded human chromosomes by in situ hybridization.

Authors:  M E Harper; G F Saunders
Journal:  Chromosoma       Date:  1981       Impact factor: 4.316

7.  Differential expression of the amv gene in human hematopoietic cells.

Authors:  E H Westin; R C Gallo; S K Arya; A Eva; L M Souza; M A Baluda; S A Aaronson; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  Molecular cloning of the avian erythroblastosis virus genome and recovery of oncogenic virus by transfection of chicken cells.

Authors:  B Vennström; L Fanshier; C Moscovici; J M Bishop
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

9.  Molecular cloning and characterization of avian sarcoma virus circular DNA molecules.

Authors:  W J DeLorbe; P A Luciw; H M Goodman; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model.

Authors:  T U Semple; L A Quinn; L K Woods; G E Moore
Journal:  Cancer Res       Date:  1978-05       Impact factor: 12.701

View more
  36 in total

1.  Distinct cellular factors regulate the c-myb promoter through its E2F element.

Authors:  M R Campanero; M Armstrong; E Flemington
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

Review 2.  Demystified ... oncogenes.

Authors:  Y L Wallis; F Macdonald
Journal:  Mol Pathol       Date:  1999-04

3.  Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter.

Authors:  J L Evans; T L Moore; W M Kuehl; T Bender; J P Ting
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 4.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

5.  Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines.

Authors:  A J Linnenbach; K Huebner; E P Reddy; M Herlyn; A H Parmiter; P C Nowell; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.

Authors:  C A Cartwright; A I Meisler; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

7.  Transcriptional trans-repression by the c-myb proto-oncogene product.

Authors:  H Nakagoshi; T Nagase; Y Ueno; S Ishii
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

8.  Isolation of human cDNA clones of myb-related genes, A-myb and B-myb.

Authors:  N Nomura; M Takahashi; M Matsui; S Ishii; T Date; S Sasamoto; R Ishizaki
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

9.  Mouse chromosomal mapping of a murine leukemia virus integration region (Mis-1) first identified in rat thymic leukemia.

Authors:  P Jolicoeur; L Villeneuve; E Rassart; C Kozak
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

10.  MYB suppresses differentiation and apoptosis of human breast cancer cells.

Authors:  Yvette Drabsch; Ramsay G Robert; Thomas J Gonda
Journal:  Breast Cancer Res       Date:  2010-07-26       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.